Back to top

Nuwellis’ REVERSE-HF Trial Termination: What It Means for NUWE Investors

Nuwellis, Inc. ($NUWE) announced an update on their ongoing clinical study. The REVERSE-HF trial, officially titled “A Randomized Controlled Study ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nuwellis, Inc. (NUWE)